293 SFM II es una formulación sin suero y baja en proteínas (Nota:Se ha presentado un archivo principal del medioMás información
Have Questions?
Número de catálogo
Cantidad
11686029
1000 mL
Número de catálogo 11686029
Precio (USD)
-
Cantidad:
1000 mL
Customize this product
293 SFM II es una formulación sin suero y baja en proteínas (<10 μg/ml) optimizada para cultivos en suspensión de alta densidad de células 293 (1).(No es adecuado para cultivos adherentes de células 293).Este producto sustituye a 293 SFM (n.° de cat.cat. 10970-010).293 SFM II está libre de material de origen animal.Formulado sin L-glutamina para aumentar la estabilidad; añadir 20 ml de L-glutamina 200 mM o 20 ml de suplemento GlutaMAX™-I por cada 1000 ml de medio antes de su uso.
Nota: Se ha presentado un archivo principal del medio 293 a la FDA.Para obtener un permiso para hacer una referencia cruzada al archivo principal, es necesario contactar con los servicios de asistencia técnica o su representante de ventas local.
Para su uso en investigación o procesos de fabricación posteriores. No apto para uso diagnóstico ni para la administración directa en seres humanos ni en animales.
Especificaciones
Línea de células293F, 293 (HEK)
Línea de productosGibco
Tipo de productoMedio sin suero (SFM)
Cantidad1000 mL
Condiciones de envíoTemperatura ambiente
ClasificaciónLibre de material de origen animal, bajo en proteínas, sin suero
Culture TypeCultivos celulares en suspensión
FormularioLíquido
Serum LevelSin suero
Sin aditivosSin glutamina
Unit SizeEach
Contenido y almacenamiento
Almacenar en el refrigerador (2–8 °C) y proteger de la luz.
Preguntas frecuentes
How do I adapt my cells to serum-free medium?
Cells can be adapted by Sequential or Direct Adaptation. Suggested protocols for each are below, and you can also find more information by searching "Adaptation of Cell Cultures to a Serum-Free Medium" from our website home page.
SEQUENTIAL ADAPTATION
1) Subculture the cells growing in serum-supplemented medium into a 25%:75% mixture of SFM and serum supplemented medium.
2) When the cell density is 5 x 10E5 cells/ml, subculture the cells into a 50%:50% mixture of SFM and serum supplemented medium at a cell density 2.5 x 10E5 to 3 x 10E5 cells/ml.
3) Continue to subculture after the cell density 5 x 10E5 cells/ml in gradually increasing proportions of SFM until the serum is ~0.1% with about 85% cell viability.
4) Subculture the cells into SFM with an innoculum of 2.5 x 10E5 to 3 x 10E5 cells/ml.
5) When the cell density is 1 x 10E6 to 3 x 10E6 cells/ml (4 to 6 days post planting) subculture the cells again.
6) Stock cultures of SFM adapted cells should be subcultured in SFM every 3 to 5 days when the cell density is 1 x 10E6 to 3 x 10E6 cells/ml with 90% viability.
DIRECT ADAPTATION
Some cells can be directly adapted from serum-containing medium to SFM. For direct adaptation, the cell innoculum should be 1.5 x 10E5 to 3 x 10E5 cells/ml.
Cells should be subcultured when the cell density is 1 x 10E6 to 3 x 10E6 cells/ml. Cells are fully adapted to SFM when the cell density is 2 x 10E6 to 4 x 10E6 cells/ml after 4 to 7 days in culture.
Stock cultures of cells adapted to SFM should be subcultured in SFM every 3 to 5 days when the cell density is 1 x 10E6 to 3 x 10E6 cells/ml with 90% viability.
Why is it necessary to gradually adapt the cells to serum-free medium?
Some cells, such as insect cells, are sensitive to changes in their medium. By sequentially adapting cells, the medium is changed with minimal effects on cell growth.
Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses.
Authors:Radoshitzky SR, Abraham J, Spiropoulou CF, Kuhn JH, Nguyen D, Li W, Nagel J, Schmidt PJ, Nunberg JH, Andrews NC, Farzan M, Choe H,
Journal:Nature
PubMed ID:17287727
'At least five arenaviruses cause viral haemorrhagic fevers in humans. Lassa virus, an Old World arenavirus, uses the cellular receptor alpha-dystroglycan to infect cells. Machupo, Guanarito, Junin and Sabia viruses are New World haemorrhagic fever viruses that do not use alpha-dystroglycan. Here we show a specific, high-affinity association between transferrin ... More